Loading...
XSHG
600796
Market cap786mUSD
Dec 05, Last price  
6.42CNY
1D
0.47%
1Q
11.27%
Jan 2017
-48.35%
Name

Zhejiang Qianjiang Biochemical Co Ltd

Chart & Performance

D1W1MN
XSHG:600796 chart
P/E
34.77
P/S
3.15
EPS
0.18
Div Yield, %
0.48%
Shrs. gr., 5y
23.52%
Rev. gr., 5y
35.98%
Revenues
1.77b
-13.08%
285,569,137429,189,788416,659,491378,366,167357,155,423431,994,267558,968,655445,941,810482,120,871398,086,530474,020,050444,081,082467,584,528442,733,052380,287,652429,593,8772,030,900,9822,008,864,5422,034,337,2621,768,342,000
Net income
160m
-24.06%
28,467,66030,484,65232,452,504026,318,05049,678,93510,036,87217,625,94930,644,44322,390,10126,543,62332,832,07041,011,138026,573,6378,103,591147,938,274206,045,309210,686,886160,004,000
CFO
373m
+6.00%
094,428,2804,350,55222,743,10926,870,8950150,272,650160,022,80374,767,15262,087,01248,957,31729,755,17059,773,38455,556,57531,935,01080,633,021368,653,556401,938,595352,025,638373,146,000
Dividend
Jun 27, 20240.031 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Qianjiang Biochemical Co., Ltd. manufactures and sells biological pesticides and veterinary drugs, and pharmaceutical intermediates in China. The company provides biopesticide products comprising validamycin, gibberellic acid, abamectin, methylamino abamectin, and other products; biological drugs, including colistin sulfate premix and colistin sulphate; biological drugs intermediates; and feed additives. It also offers external heating services. In addition, the company exports its products to the United States, West Europe, South America, and Southeast Asia. Zhejiang Qianjiang Biochemical Co., Ltd. was founded in 1970 and is based in Haining, China.
IPO date
Apr 08, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT